Foghorn Therapeutics | 4:持股变动声明-股东 Flagship Pioneering Inc.
Foghorn Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Noubar Afeyan(22.9%),Flagship Ventures Fund V, L.P.(16.9%)等
Foghorn Therapeutics | 3:首次持股声明-股东 Flagship Pioneering Fund VII General Partner LLC
Foghorn Therapeutics | 4:持股变动声明-高管 Humer Kristian
Foghorn Therapeutics | 3:首次持股声明-高管 Humer Kristian
Foghorn Therapeutics | 4:持股变动声明-高管 Cavalie Fanny
Foghorn Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-FMR LLC(6.656%),Abigail P. Johnson(6.656%)
Foghorn Therapeutics | 4:持股变动声明-高管 GOTTSCHALK ADRIAN
Foghorn Therapeutics | 4:持股变动声明-高管 Cardama Alfonso Quintas
Foghorn Therapeutics | 4:持股变动声明-高管 Cavalie Fanny
Foghorn Therapeutics | 4:持股变动声明-高管 Costa Carlos
Foghorn Therapeutics | 4:持股变动声明-高管 Bellon Steven F.
Foghorn Therapeutics | 4:持股变动声明-高管 LaCascia Michael
Foghorn Therapeutics | 4:持股变动声明-高管 Reine Allan
Foghorn Therapeutics | 4:持股变动声明-董事 SMITH IAN F
Foghorn Therapeutics | 4:持股变动声明-高管 Agresta Samuel
Foghorn Therapeutics | 4:持股变动声明-高管 Cardama Alfonso Quintas
Foghorn Therapeutics | 3:首次持股声明-高管 Cardama Alfonso Quintas
Foghorn Therapeutics | 4:持股变动声明-高管 Agresta Samuel
Foghorn Therapeutics | 4:持股变动声明-首席执行官 GOTTSCHALK ADRIAN
暂无数据